Haemonetics Corp
NYSE:HAE
Haemonetics Corp
NYSE:HAE
Price:
93.37 USD
-1.92%
Market Closed
Updated:
May 8, 2024
Haemonetics Corp
Cash from Investing Activities
|
Haemonetics Corp
Cash from Investing Activities Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Investing Activities
-$327.3m
|
CAGR 3-Years
-99%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-14%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Investing Activities
-$659.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-12%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Investing Activities
-$95m
|
CAGR 3-Years
57%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Investing Activities
-$195.9m
|
CAGR 3-Years
27%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Investing Activities
-$56.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-32%
|
See Also
What is Haemonetics Corp's Cash from Investing Activities?
Cash from Investing Activities
-327.3m
USD
-327.3m
USD
Based on the financial report for Dec 30, 2023, Haemonetics Corp's Cash from Investing Activities amounts to -327.3m USD.
What is Haemonetics Corp's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-14%
-14%
Over the last year, the Cash from Investing Activities growth was -104%. The average annual Cash from Investing Activities growth rates for Haemonetics Corp have been -99% over the past three years , -22% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
